What Has Been The Evolution of the Neurovascular Embolization Devices Market in Recent Years?
The neurovascular embolization devices market has seen considerable growth due to a variety of factors.
• The neurovascular embolization devices market has grown steadily in recent years. It will grow from $1.32 billion in 2024 to $1.4 billion in 2025, with a CAGR of 6.2%.
Growth factors include the increasing prevalence of neurovascular disorders, a growing elderly population, a demand for minimally invasive procedures, and advancements in healthcare infrastructure.
How Will the Neurovascular Embolization Devices Market?
The neurovascular embolization devices market is expected to maintain its strong growth trajectory in upcoming years.
• The neurovascular embolization devices market is expected to grow significantly, reaching $1.8 billion by 2029 with a CAGR of 6.5%.
This growth is driven by expanding applications in emerging markets, a focus on patient-centric care, increased awareness of neurovascular disorders, advancements in imaging technologies, and growing investments in R&D. Trends in this market include personalized treatment, AI integration in treatment planning, the rise of next-generation embolic materials, a shift towards outpatient procedures, and innovative embolization techniques.
Which Factors Are Boosting Growth In The Neurovascular Embolization Devices Market?
The rise in hemorrhages is expected to propel the growth of the neurovascular embolization devices market. Hemorrhages are uncontrolled internal bleeding that can result in severe complications. The prevalence of hemorrhages is increasing due to aging populations, hypertension, and the use of anticoagulant medications. Neurovascular embolization devices are used to block abnormal blood vessels during hemorrhagic strokes, helping prevent further brain damage. For example, in February 2024, King's College London predicted a 59.4% increase in intracerebral hemorrhage cases among people aged 70 to 95 by 2050, driving the demand for neurovascular embolization devices.
What Key Areas Define The Segmentation Of The Global Neurovascular Embolization Devices Market?
The neurovascular embolization devices market covered in this report is segmented –
1) By Product: Embolization Coils, Liquid Embolic Systems, Flow Diversion Stents, Aneurysm Clips, Other Products
2) By Treatment: Ischemic Stroke Solution, Hemorrhagic Stroke Solutions
3) By Indication: Brain Aneurysms, Arteriovenous Malformation, Other Indications
4) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Embolization Coils: Detachable Coils, Bare Platinum Coils, Coils With Hydrogel Coatings
2) By Liquid Embolic Systems: Gluteraldehyde-Based Liquid Embolization, Onyx Liquid Embolic System
3) By Flow Diversion Stents: Stents With Dual-Layer Technology, Flow Diverters For Aneurysm Treatment
4) By Aneurysm Clips: Titanium Clips, Stainless Steel Clips
5) By Other Products: Balloons For Embolization, Microcatheters
Pre-Book The Neurovascular Embolization Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Neurovascular Embolization Devices Market?
Leading firms in the neurovascular embolization devices sector are prioritizing the creation of technologically advanced products, such as those featuring shield technology, with the aim of obtaining a competitive advantage in the market. Shield Technology is an innovative feature designed to improve the efficiency and safety of these devices, and to enhance their overall durability and lifespan. As an example, in June 2022, the healthcare technology firm Medtronic PLC, which is based in Ireland, launched the fourth generation Pipeline Vantage with Shield Technology in India. This flow diverter has improved design features for greater user-friendliness and reliability during endovascular procedures. The device aids in cell growth in the blood vessel's inner lining, providing a structural support that helps in the less invasive treatment of aneurysms, reduces rupture risk, and improves patient recovery rates.
Who Are the Key Players In The Neurovascular Embolization Devices Market?
Major companies operating in the neurovascular embolization devices market are:
• Johnson & Johnson
• Abbott Laboratories
• Medtronic plc
• Heraeus Holding
• Stryker Corporation
• Boston Scientific Corporation
• Kaneka Corporation
• Terumo Corporation
• B Braun Melsungen AG
• Cook Medical LLC
• Integer Holdings Corporation
• Merit Medical Systems Inc.
• Penumbra Inc.
• Asahi Intecc Co Ltd.
• MicroVention Inc.
• Balt USA LLC
• Imperative Care Inc.
• InNeuroCo Inc.
• Acandis GmbH & Co KG
• Rapid Medical Ltd.
• Emboline Inc.
• InspireMD Inc.
• QXMedical LLC
• Vesalio LLC
• EmbolX Inc
What Is The Most Dominant Region In The Neurovascular Embolization Devices Market?
North America was the largest region in the neurovascular embolization devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurovascular embolization devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
